COLLECTING DUCT RENAL CELL CARCINOMA
Clinical trials for COLLECTING DUCT RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLLECTING DUCT RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for COLLECTING DUCT RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo shows promise against rare kidney cancers
Disease control OngoingThis study tests whether combining two drugs, nivolumab and cabozantinib, can shrink tumors in people with advanced or metastatic non-clear cell kidney cancer. About 60 adults who have had up to one prior treatment will receive the drug combination. The main goal is to see how ma…
Matched conditions: COLLECTING DUCT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:18 UTC
-
Triple-Drug cocktail targets rare kidney cancers
Disease control OngoingThis study tests whether a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) can safely slow the growth of advanced or spreading kidney cancer in people with rare types of the disease. About 60 adults with non-clear cell kidney cancer that cannot be surgically …
Matched conditions: COLLECTING DUCT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated May 13, 2026 16:03 UTC